> Research summary—not medical advice. This page synthesizes published research on a mechanism-level intervention. It is not a clinical recommendation.
Consult a qualified healthcare provider before making any changes to diet, supplementation, or treatment.
Intervention Summary#
Lactoferrin is an iron-binding glycoprotein that sequesters free iron from the gut lumen, starving siderophore-dependent pathogens while supporting host iron absorption via dedicated lactoferrin receptors on enterocytes. The key alternative to iron supplementation in inflammatory states where hepcidin elevation indicates functional anemia (host nutritional immunity defense), not true iron deficiency.
Evidence#
Neonatal NEC prevention: RCTs demonstrate reduced necrotizing enterocolitis incidence in preterm infants receiving bovine lactoferrin. Iron status in pregnancy: Lactoferrin supplementation improves hemoglobin and ferritin without the gastrointestinal side effects of ferrous sulfate, and without feeding gut pathogens. Anti-inflammatory: Reduces CRP and intestinal inflammation markers in multiple clinical settings.
In vitro: Potent inhibition of biofilm formation by E. coli, Pseudomonas, and Staphylococcus.
Mechanism#
Iron sequestration: Lactoferrin binds free iron(III) (Fe3+) with extremely high affinity, removing the substrate that siderophore-producing pathogens require for virulence.
Selective iron delivery: Host enterocytes express lactoferrin receptors, enabling iron absorption even when luminal iron is sequestered—the host gets iron, pathogens do not.
Anti-biofilm: Lactoferrin disrupts iron-dependent biofilm architecture by chelating the structural iron that cross-links extracellular matrix. Immunomodulation: Activates NK cells, promotes macrophage phagocytosis, modulates cytokine production.
Clinical Context#
Lactoferrin supplementation is most valuable when conventional iron supplementation would be counterproductive—inflammatory anemia, active IBD, conditions with siderophore-producing pathogen enrichment. See STOPs for iron supplementation in specific conditions. Bovine lactoferrin (200-400mg/day) is the most studied form.
It survives gastric transit partially intact and retains iron-binding capacity in the small intestine.
> Educational content, not medical advice. This page describes mechanisms by which the intervention interacts with the microbiome and metal ecology. It is not a treatment recommendation.
Clinical decisions about any intervention should be made with a qualified healthcare practitioner who knows your individual history.
Article network
Pages linking here 12
Connect the evidence
Publicly readable discussion by ORCID-authenticated researchers. Questions, interpretation, methods, corrections, and new evidence stay attached to this record.
No discussion yet. Start with a precise question or a source-backed observation.
Activity and accepted changes
Accepted researcher context, editorial status, public discussion, and upstream Git revisions are shown together. Pending, declined, and withdrawn proposals remain private.
- published revision
massive wiki expansion: 149 stubs fixed, 100+ new pages, Rule 15 scan, keystone papers
WikiBiome Deploy Bot · +11 −11
Inspect exact Git diff ↗ - published revision
Adversarial audit fixes: confidence downgrades, disclaimers, STOP safety, entity cleanup
WikiBiome Deploy Bot · +7 −0
Inspect exact Git diff ↗ - published revision
Health check fixes: 40 intervention pages + 14 entity Connections sections
WikiBiome Deploy Bot · +54 −0
Inspect exact Git diff ↗